Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
NKT Therapeutics
NKT Therapeutics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
NKT Therapeutics
Total Funding
$12 M
NKT Therapeutics Summary
Company Summary
Overview
NKT Therapeutics is a biotech company developing therapeutics based on immune cells called natural killer T (“NKT”) cells. It provides medications to treat sickle cell anemia, autoimmune and inflammatory diseases, cancer, asthma, and dermatitis.
Type
Private
Status
Active
Founded
2008
HQ
Sharon, MA, US
|
view all locations
Website
http://www.nktrx.com/main_page.html
Cybersecurity rating
Sectors
Healthcare
biotech
drug development
life sciences
oncology
therapy
Homepage
Linkedin
Table of Contents
Locations
Competitors
Locations
View all
1 location detected
Sharon, MA
HQ
United States
58 Deborah Sampson St
Competitors and Similar Companies
Achieve Life Sciences
Healthcare - Public
Morphogenesis
Healthcare - Private
United Therapeutics
Healthcare - Public
Immunovative Therapies
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top